Pro-nociceptive action of cholecystokinin in the periaqueductal grey: A role in neuropathic and anxiety-induced hyperalgesic states
Author:
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 32 (4) , 852-862
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insultPain, 2008
- Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potentialCurrent Opinion in Pharmacology, 2007
- The CCK-system mediates adaptation to novelty-induced stress in the rat: A pharmacological evidenceNeuroscience Letters, 2007
- PAG mu opioid receptor activation underlies sex differences in morphine antinociceptionBehavioural Brain Research, 2007
- Cellular action of cholecystokinin-8S-mediated excitatory effects in the rat periaqueductal grayLife Sciences, 2006
- Immunolocalization of CCK1R in rat brain using a new anti-peptide antibodyNeuroscience Letters, 2004
- Vigabatrin Decreases Cholecystokinin-Tetrapeptide (CCK-4) Induced Panic in Healthy VolunteersNeuropsychopharmacology, 2001
- Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic ratsNeuroscience Letters, 1996
- Local administration of morphine decreases the extracellular level of GABA in the periaqueductal gray matter of freely moving ratsNeuroscience Letters, 1996
- Stress hyperalgesia in rats: An experimental animal model of anxiogenic hyper-algesia in humanLife Sciences, 1982